(Q38132635)

29 August 2017

Epidemiology of Chagas disease in Europe: many calculations, little knowledge (English)

1 reference

29 August 2017

0 references

1 reference

3

Georg Ertl

1 reference

29 August 2017

6

Oliver Ritter

1 reference

29 August 2017

Jörn Strasen

1

1 reference

29 August 2017

Tatjana Williams

series ordinal

2

1 reference

29 August 2017

Thomas Zoller

series ordinal

4

1 reference

29 August 2017

August Stich

series ordinal

5

1 reference

29 August 2017

29 August 2013

1 reference

Clinical Research in Cardiology

29 August 2017

1 reference

29 August 2017

103

1 reference

29 August 2017

1

1 reference

29 August 2017

1-10

1 reference

https://scigraph.springernature.com/pub.10.1007/s00392-013-0613-y

29 August 2017

0 references

cites work

Amiodarone inhibits Trypanosoma cruzi infection and promotes cardiac cell recovery with gap junction and cytoskeleton reassembly in vitro

1 reference

https://api.crossref.org/works/10.1007%2FS00392-013-0613-Y

Large urban outbreak of orally acquired acute Chagas disease at a school in Caracas, Venezuela

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00392-013-0613-Y

Prevalence of Trypanosoma cruzi infection in pregnant Latin American women and congenital transmission rate in a non-endemic area: the experience of the Valencian Health Programme (Spain).

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00392-013-0613-Y

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00392-013-0613-Y

Evaluation and treatment of chagas disease in the United States: a systematic review

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00392-013-0613-Y

Cardiac involvement in African and American trypanosomiasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00392-013-0613-Y

A randomized trial of carvedilol after renin-angiotensin system inhibition in chronic Chagas cardiomyopathy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00392-013-0613-Y

Awareness of stroke risk in chagasic stroke patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00392-013-0613-Y

Emerging and under-recognized Chagas cardiomyopathy in non-endemic countries

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00392-013-0613-Y

Effects of metoprolol in chagasic patients with severe congestive heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00392-013-0613-Y

Chagas disease in Spain, the United States and other non-endemic countries

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00392-013-0613-Y

Pathophysiology of the heart in Chagas' disease: current status and new developments

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00392-013-0613-Y

Prevalence, clinical staging and risk for blood-borne transmission of Chagas disease among Latin American migrants in Geneva, Switzerland

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00392-013-0613-Y

The early implementation of Trypanosoma cruzi antibody screening of donors and donations within England: preempting a problem

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00392-013-0613-Y

21 January 2018

Chagas disease, France

1 reference

https://api.crossref.org/works/10.1007%2FS00392-013-0613-Y

The BENEFIT trial: testing the hypothesis that trypanocidal therapy is beneficial for patients with chronic Chagas heart disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00392-013-0613-Y

Activities of the triazole derivative SCH 56592 (posaconazole) against drug-resistant strains of the protozoan parasite Trypanosoma (Schizotrypanum) cruzi in immunocompetent and immunosuppressed murine hosts

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00392-013-0613-Y

Implantable cardioverter defibrillators and Chagas' disease: results of the ICD Registry Latin America

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00392-013-0613-Y

Chagas disease in Spain: need for further public health measures

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00392-013-0613-Y

Cardiac involvement is a constant finding in acute Chagas' disease: a clinical, parasitological and histopathological study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00392-013-0613-Y

Chagas disease in pregnancy: a non-endemic problem in a globalized world

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00392-013-0613-Y

Successful treatment with posaconazole of a patient with chronic Chagas disease and systemic lupus erythematosus

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00392-013-0613-Y

Challenges and opportunities for primary, secondary, and tertiary prevention of Chagas' disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00392-013-0613-Y

Chagas heart disease: pathophysiologic mechanisms, prognostic factors and risk stratification.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00392-013-0613-Y

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00392-013-0613-Y

Development and validation of a risk score for predicting death in Chagas' heart disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00392-013-0613-Y

Predictors of mortality in chronic Chagas disease: a systematic review of observational studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00392-013-0613-Y

Chagas disease among the Latin American adult population attending in a primary care center in Barcelona, Spain

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00392-013-0613-Y

Trypanosoma cruzi, the etiologic agent of Chagas' disease: status in the blood supply in endemic and nonendemic countries

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00392-013-0613-Y

Chagas disease: a Latin American health problem becoming a world health problem

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00392-013-0613-Y

Epidemiology of Chagas disease in non-endemic countries: the role of international migration.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00392-013-0613-Y

Experimental chemotherapy against Trypanosoma cruzi infection using ruthenium nitric oxide donors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00392-013-0613-Y

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00392-013-0613-Y

Multicenter randomized trial of cell therapy in cardiopathies - MiHeart Study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00392-013-0613-Y

21 January 2018

1 reference

12 December 2020

Chagas disease (American trypanosomiasis) – fact sheet (revised in August 2012)

1 reference

12 December 2020

Control of Chagas disease. Report of a WHO Expert Committee

1 reference

12 December 2020

[Chagas disease in the Netherlands: an estimate of the number of patients].

1 reference

12 December 2020

Chagas disease at the crossroad of international migration and public health policies: why a national screening might not be enough.

1 reference

12 December 2020

Effect of isosorbide dinitrate on gastroesophageal reflux in healthy volunteers and patients with Chagas' disease

1 reference

12 December 2020

Nitric oxide is involved in control of Trypanosoma cruzi-induced parasitemia and directly kills the parasite in vitro

1 reference

12 December 2020

Chagas heart disease: report on recent developments

1 reference

12 December 2020

[Transfusion-transmitted protozoal infections: what is the risk in non-endemic countries?].

1 reference

12 December 2020

Chagas' disease in Sweden--great need of guidelines for testing. Probably hundreds of seropositive cases, only a few known

1 reference

12 December 2020

The right ventricle in Fabry disease: natural history and impact of enzyme replacement therapy

1 reference

12 December 2020

Chagas disease in Italy: breaking an epidemiological silence

1 reference

12 December 2020

Chagas cardiomyopathy: Europe is not spared!

1 reference

12 December 2020

The paradox of survival results after heart transplantation for cardiomyopathy caused by Trypanosoma cruzi. First Guidelines Group for Heart Transplantation of the Brazilian Society of Cardiology

1 reference

12 December 2020

The discovery of Trypanosoma cruzi and Chagas disease (1908-1909): tropical medicine in Brazil

1 reference

12 December 2020

Clinical course of Chagas' heart disease: a comparison with dilated cardiomyopathy

1 reference

12 December 2020

I Latin American Guidelines for the diagnosis and treatment of Chagas' heart disease: executive summary

1 reference

12 December 2020

Transfusion-transmitted Chagas' disease

1 reference

12 December 2020

Surveillance of Chagas disease in pregnant women in Madrid, Spain, from 2008 to 2010.

1 reference

12 December 2020

Pharmacological interventions for treating heart failure in patients with Chagas cardiomyopathy

1 reference

12 December 2020

Targeted screening and health education for Chagas disease tailored to at-risk migrants in Spain, 2007 to 2010.

1 reference

12 December 2020

Life expectancy analysis in patients with Chagas' disease: prognosis after one decade (1973-1983)

1 reference

12 December 2020

Myocardial parasite persistence in chronic chagasic patients

1 reference

12 December 2020

Immunopathology of Chagas disease

1 reference

12 December 2020

[Epidemiological surveillance of vertically-transmitted Chagas disease at three maternity hospitals in the Valencian Community]

1 reference

12 December 2020

Chagas disease in European countries: the challenge of a surveillance system.

1 reference

12 December 2020

10.1007/S00392-013-0613-Y

Identifiers

DOI

1 reference

29 August 2017

1 reference